Adial Pharmaceuticals Inc
NASDAQ:ADIL
Adial Pharmaceuticals Inc
NASDAQ:ADIL
Price:
1.97
USD
7.65%
Market Closed
Market Cap:
$2.2m
Balance Sheet
Balance Sheet Decomposition
Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc
Balance Sheet
Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc
Currency: USD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
4
|
7
|
4
|
6
|
4
|
3
|
4
|
6
|
|
| Cash Equivalents |
0
|
0
|
0
|
4
|
7
|
4
|
6
|
4
|
3
|
4
|
6
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
5
|
8
|
5
|
6
|
5
|
3
|
4
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-32%
|
0
-80%
|
5
+15 567%
|
8
+63%
|
5
-29%
|
7
+36%
|
6
-23%
|
5
-17%
|
5
+6%
|
7
+32%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
0
|
1
|
2
|
3
|
2
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+420%
|
1
+296%
|
0
-75%
|
1
+108%
|
2
+180%
|
4
+163%
|
2
-38%
|
1
-73%
|
1
+49%
|
1
+43%
|
|
| Equity | ||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
10
|
10
|
0
|
12
|
21
|
32
|
51
|
64
|
69
|
82
|
90
|
|
| Additional Paid In Capital |
10
|
10
|
1
|
16
|
28
|
35
|
54
|
67
|
73
|
86
|
95
|
|
| Total Equity |
0
N/A
|
0
N/A
|
1
-900%
|
4
N/A
|
7
+61%
|
4
-44%
|
4
-12%
|
3
-7%
|
4
+24%
|
4
0%
|
5
+30%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-32%
|
0
-80%
|
5
+15 567%
|
8
+63%
|
5
-29%
|
7
+36%
|
6
-23%
|
5
-17%
|
5
+6%
|
7
+32%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
